Multiple organ failure during interleukin-2 administration and LAK cells infusion
Authors:
- 1 October 1988
- journal article
- case report
- Published by Springer Nature in Intensive Care Medicine
- Vol. 14 (6) , 666-667
Abstract
Adoptive immunotherapy is a new promising treatment for cancer but is associated with severe toxicity mainly related to a capillary leak syndrome. We report the case of a patient with metastatic hypernephroma, who had many complications such as coma, renal failure, pulmonary edema, life-threatening acidosis, cardiac arrhythmias and venous thrombosis. Critical care specialists should be aware of this type of cancer therapy because of multiple side effects requiring ICU supportive care.Keywords
This publication has 5 references indexed in Scilit:
- Effects of Interleukin-2 on Renal Function in Patients Receiving Immunotherapy for Advanced CancerAnnals of Internal Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroids.Journal of Clinical Oncology, 1987
- EFFECT OF CORTICOSTEROID ON THE ANTITUMOR-ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN MICE1986
- Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.The Journal of Immunology, 1986